Huawei Watch GT 7 and Watch D3: 21-Day Battery Meets Wrist Blood Pressure Tracking

Huawei Watch GT 7 arrives with the Watch D3

Huawei unveiled two smartwatches this October: the Watch GT 7 series and the Watch D3. The pair extends a lineup that already leads the wrist-worn market. According to IDC's report on the first half of 2026, Huawei kept its position as the world's top smartwatch and wristband company by shipment volume, with more than 20 percent market share. The Huawei Watch GT 7 is the volume play in that lineup, and the Watch D3 is the health play.

The GT 7 is built for daily workouts and outdoor use, with advanced sports and health tracking and a battery rated up to 21 days. The Watch D3 builds on Huawei's wrist-based ambulatory blood pressure monitoring, promising a less disruptive 24-hour blood pressure tracking experience plus broader cardiovascular health features. Together they show where Huawei thinks wearables are heading: longer battery, more medical-grade measurements, and less time spent charging.

Huawei Watch GT 7 battery life is the headline spec

Battery life is the GT 7's strongest argument, and it is not close. Twenty-one days is roughly three times what most mainstream smartwatches manage, and it changes how you use the device. You stop thinking about charging as a nightly chore and start treating it like a fortnightly one. Sleep tracking gets better too, because the watch is actually on your wrist at night instead of sitting on a charger.

The trade-off is familiar to anyone who has used a GT-series watch before. Huawei's watches run their own software, not Wear OS or watchOS, so third-party app support is thinner than on a Pixel Watch or Apple Watch. Notifications, calls, and health data work well. The deep app ecosystem does not. If your watch is a phone extension first and a health tracker second, that trade may not suit you. If it is the other way around, 21 days is a serious advantage.

Sports tracking covers the usual range of workouts and outdoor activity, with more accurate monitoring and more detailed insights than the previous generation, according to Huawei. The company is pitching the GT 7 as a watch for people who train regularly and travel, where charging opportunities are not guaranteed. That is a fair pitch. A watch that dies on day two of a hiking trip is a paperweight, and Huawei knows its audience.

The Watch D3 takes blood pressure seriously

The Watch D3 is the more interesting device, even if it will sell fewer units. Wrist-based ambulatory blood pressure monitoring (ABPM) is a genuinely hard problem: a cuff on the upper arm is the clinical standard, and the wrist is a noisier place to measure from. Huawei's earlier Watch D established that wrist ABPM could work at all. The D3 aims to make it less disruptive across a full 24 hours, so the measurements interfere less with sleep and daily life.

Why does 24-hour tracking matter? Blood pressure is not one number. It rises and falls through the day, and the nighttime pattern carries its own clinical meaning. A single reading at a pharmacy tells you little. A full day of readings, including overnight, tells a doctor much more. That is the promise of the D3: not a replacement for a doctor's cuff, but a way to arrive at an appointment with real data instead of a vague memory.

Treat the health claims with the right level of trust. Wrist blood pressure readings are useful for trends and for flagging changes, but they are not a diagnosis. Anyone with hypertension should still confirm readings with a proper cuff and talk to a clinician before changing medication. Huawei's health features are best understood as an early-warning and tracking system, not a medical device in your pocket. The same caution applies to every wearable that reports a health number, from Suunto's Race 3S to the modular Alloop Trio.

Who should buy which watch

The choice between the two is straightforward. Buy the GT 7 if you want a long-lasting sports watch with solid health tracking and you do not need a deep app store. Buy the Watch D3 if blood pressure tracking is a genuine health priority for you or someone you care for, and you want that data collected passively across the day and night.

Neither watch is the right pick if you live inside Google's or Apple's ecosystem and want your watch to run the same apps as your phone. Huawei's wearables are strongest as independent health and fitness devices, and weakest as phone accessories. That is a deliberate trade, and Huawei's market share suggests plenty of buyers accept it.

The wider context matters too. Google's Fitbit Edge sits at around $180 with Gemini coaching, and Huawei is answering with longer battery and deeper health sensors rather than a smarter assistant. The wearable market is splitting into two philosophies: the watch as an AI companion, and the watch as a health instrument. Huawei has picked its side clearly, and the GT 7 and D3 are the purest expression of it yet.